Group 1 - BeiGene (06160.HK) reported total revenue of $1.117 billion for Q1, a year-on-year increase of 49%; adjusted net profit reached $136 million, marking a turnaround from losses. The growth was primarily driven by increased sales of Brukinsa in the US and Europe [1] - Eddingpharm (01541.HK) received a second recent payment of $5 million from Axion Bio under a licensing and collaboration agreement. The company expects to receive up to $30 million in potential future payments [1] - Geely Automobile (00175.HK) submitted a non-binding offer letter to Zeekr, indicating an intention to propose privatization at a valuation of $2.566 per share or $25.66 per American depositary share [1] - Hong Kong Broadband (01310.HK) announced that China Mobile Hong Kong completed the acquisition of a 15.46% stake in the company [1] - Anta Sports (02020.HK) adjusted the conversion price of its €1.5 billion zero-coupon guaranteed convertible bonds to HK$102.62 per share [1] - Zhengrong Real Estate (06158.HK) reported a cumulative contract sales amount of approximately $1.496 billion for the first four months, a year-on-year decrease of 33.06% [1] - Ronshine China (03301.HK) recorded contract sales of $327 million in April, with a cumulative total of $1.42 billion from January to April [1] Group 2 - Qingdao Beer (00168.HK) plans to acquire all shares of Jimo Huangjiu held by Xinhua Jin Group and Lujin Group [2]